A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared to BFF in Participants of 4 to Less Than 12 Years of Age With Asthma

ClinicalTrials.gov ID: NCT07525375

Public ClinicalTrials.gov record NCT07525375. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Sep 8, 2026, 2:44 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II, Randomized, Double-blind, 3-Period Cross-over, Dose-ranging Study to Assess the Efficacy and Safety of Glycopyrronium (GP) Versus Placebo in Participants of 4 to Less Than 12 Years of Age With Asthma Receiving Background Budesonide and Formoterol Fumarate (BFF)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the effect of 2 different GP metered dose inhaler (MDI) doses relative to placebo MDI as add-on treatment to BFF MDI on lung function in participants 4 to less than 12 years of age with asthma.

Study identification

NCT ID: NCT07525375
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 2
Lead sponsor: AstraZeneca; Industry
Enrollment: 69 participants

Conditions and interventions

Conditions

Asthma

Interventions

GP MDI Combination Product
BFF MDI Combination Product
Placebo MDI Combination Product

Combination Product

Eligibility (public fields only)

Age range: 4 Years to 11 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Apr 13, 2026
Primary completion: May 22, 2029
Completion: May 22, 2029
Last update posted: Aug 26, 2026

2026 – 2029

United States locations

U.S. sites: 15
U.S. states: 9
U.S. cities: 15

Facility	City	State	ZIP	Site status
Research Site	Bakersfield	California	93301	Recruiting
Research Site	Lancaster	California	93534	Recruiting
Research Site	Long Beach	California	90806	Recruiting
Research Site	San Diego	California	92123	Not yet recruiting
Research Site	Miami	Florida	33186	Recruiting
Research Site	Pembroke Pines	Florida	33026	Recruiting
Research Site	Saint Cloud	Florida	34769	Recruiting
Research Site	Owensboro	Kentucky	42301	Recruiting
Research Site	Lafayette	Louisiana	70508	Recruiting
Research Site	Boston	Massachusetts	02114	Not yet recruiting
Research Site	Columbia	Missouri	65203	Recruiting
Research Site	Cincinnati	Ohio	45229	Not yet recruiting
Research Site	Oklahoma City	Oklahoma	73120	Recruiting
Research Site	Lewisville	Texas	75067	Recruiting
Research Site	San Antonio	Texas	78249	Not yet recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 28 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT07525375, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Aug 26, 2026 · Synced Sep 8, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07525375 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →